Kaiser Clinic and Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2014
NCT03074448
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Kaiser Clinic and Hospital

Active Ingredients

Drugs in Phase 3 Trials (1)

sodium picosulfate (Preopik) (1 trial)

Drugs in Other Trials (2)

argon (1 trial)

carbon dioxide (dry ice) (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3